Volume 9, Number 2—February 2003
Research
Using Hospital Antibiogram Data To Assess Regional Pneumococcal Resistance to Antibiotics
Table 1
Year | Percent of all isolates susceptible toa |
||||||||
---|---|---|---|---|---|---|---|---|---|
Penicillin | Erythromycin | Cefotaxime | Levofloxacin | Tmp-smxb | Tetracycline | Clindamycin | Vancomycin | Chloram-phenicol | |
1996 |
65 (18; 1,854) |
78 (4; 488) |
85(9; 985) |
100 (1; 205) |
64 (5; 626) |
96 (2; 254) |
90(4; 492) |
100 (7; 580) |
93 (2; 381) |
1997 |
63 (24; 2,406) |
69 (11; 786) |
80 (13; 1,272) |
100 (1; 283) |
57 (11; 786) |
79 (4; 66) |
76 (7; 655) |
100 (11; 903) |
95 (3; 117) |
1998 |
56 (33; 2,827) |
64 (17; 1,095) |
83 (20; 1,970) |
92 (4; 237) |
51 (16; 975) |
83 (10; 402) |
88 (11; 606) |
100 (19; 1202) |
89 (10; 520) |
1999 |
54 (36; 3,562) |
61 (20; 1,397) |
80 (22; 2,062) |
94 (5; 525) |
51 (16; 1,068) |
84 (10; 406) |
85 (13; 1,017) |
100 (21; 1308) |
92 (9; 540) |
2000 | 52 (42; 3,497) | 61 (27; 1,762) | 77 (27; 2,296) | 98 (12; 822) | 50 (20; 1,292) | 81 (14; 717) | 88 (18; 1,238) | 100 (26; 1,648) | 94 (12; 730) |
aValues in parentheses are number of hospitals contributing data and total number of isolates reported, respectively
bTmp-smx, trimethoprim-sulfamethoxazole
Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.